408 related articles for article (PubMed ID: 29981861)
1. Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Holweg C; Itoh K; Inoue H; Hashimoto S
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):134-145.e1. PubMed ID: 29981861
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.
Katoh S; Ikeda M; Shirai R; Abe M; Ohue Y; Kobashi Y; Oka M
J Asthma; 2018 Oct; 55(10):1052-1058. PubMed ID: 29035604
[TBL] [Abstract][Full Text] [Related]
3. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
Wang J; Lv H; Luo Z; Mou S; Liu J; Liu C; Deng S; Jiang Y; Lin J; Wu C; Liu X; He J; Jiang D
Respir Res; 2018 Mar; 19(1):47. PubMed ID: 29580282
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
Takayama Y; Ohnishi H; Ogasawara F; Oyama K; Kubota T; Yokoyama A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2525-2532. PubMed ID: 30174422
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-15b-5p as a biomarker for asthma-COPD overlap.
Hirai K; Shirai T; Shimoshikiryo T; Ueda M; Gon Y; Maruoka S; Itoh K
Allergy; 2021 Mar; 76(3):766-774. PubMed ID: 32713026
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Fractional Exhaled Nitric Oxide in Elderly Patients with Asthma-chronic Obstructive Pulmonary Disease Overlap and Other Airway Inflammatory Diseases.
Shi F; Qiu C; Yu J; Yang Y; Li B; Feng M; Zhang T; Liu W
Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):232-239. PubMed ID: 29908540
[TBL] [Abstract][Full Text] [Related]
9. Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis.
Peng J; Wang M; Wu Y; Shen Y; Chen L
Int J Chron Obstruct Pulmon Dis; 2022; 17():2567-2575. PubMed ID: 36259043
[TBL] [Abstract][Full Text] [Related]
10. Asthma/obstructive pulmonary disease overlap: update on definition, biomarkers, and therapeutics.
Generoso A; Oppenheimer J
Curr Opin Allergy Clin Immunol; 2020 Feb; 20(1):43-47. PubMed ID: 31688150
[TBL] [Abstract][Full Text] [Related]
11. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
[TBL] [Abstract][Full Text] [Related]
12. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112
[TBL] [Abstract][Full Text] [Related]
13. Periostin as a biomarker for the diagnosis of pediatric asthma.
Inoue T; Akashi K; Watanabe M; Ikeda Y; Ashizuka S; Motoki T; Suzuki R; Sagara N; Yanagida N; Sato S; Ebisawa M; Ohta S; Ono J; Izuhara K; Katsunuma T
Pediatr Allergy Immunol; 2016 Aug; 27(5):521-6. PubMed ID: 27062336
[TBL] [Abstract][Full Text] [Related]
14. Association between YKL-40 and asthma: a systematic meta-analysis.
Jin Y; Song J; Xu F; Zhang D; He J; Zheng J; Zhang Y; Li J; Guo Y; Xu M; Yu X; Liu Y; Liu Q; Yan J
Sleep Breath; 2022 Sep; 26(3):1011-1022. PubMed ID: 34657273
[TBL] [Abstract][Full Text] [Related]
15. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
16. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.
Jia G; Erickson RW; Choy DF; Mosesova S; Wu LC; Solberg OD; Shikotra A; Carter R; Audusseau S; Hamid Q; Bradding P; Fahy JV; Woodruff PG; Harris JM; Arron JR;
J Allergy Clin Immunol; 2012 Sep; 130(3):647-654.e10. PubMed ID: 22857879
[TBL] [Abstract][Full Text] [Related]
17. Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify Asthma-COPD overlap.
Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Itoh K; Hashimoto S
Allergol Int; 2021 Jan; 70(1):136-139. PubMed ID: 32571644
[No Abstract] [Full Text] [Related]
18. Reference ranges for serum periostin in a population without asthma or chronic obstructive pulmonary disease.
Caswell-Smith R; Hosking A; Cripps T; Holweg C; Matthews J; Holliday M; Maillot C; Fingleton J; Weatherall M; Braithwaite I; Beasley R;
Clin Exp Allergy; 2016 Oct; 46(10):1303-14. PubMed ID: 27237923
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
Pérez de Llano L; Cosío BG; Miravitlles M; Plaza V;
Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):198-204. PubMed ID: 29229474
[TBL] [Abstract][Full Text] [Related]
20. High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Peng J; Yu Q; Fan S; Chen X; Tang R; Wang D; Qi D
Int J Chron Obstruct Pulmon Dis; 2021; 16():795-806. PubMed ID: 33814903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
